WS #10787
Moderna shares rise after Piper Sandler raises price target to $77, citing drug pipeline optimism. Ardelyx shares fall ~6% after losing appeal on Medicare Part D coverage for Xphozah. CDC raises Ebola outbreak response to Level 1, its most severe designation, signaling heightened public health risk.
Moderna Stock Rises
Moderna shares rise after Piper Sandler raises price target to $77, citing drug pipeline optimism.
Ardelyx shares fall ~6% after losing appeal on Medicare Part D coverage for Xphozah.
CDC raises Ebola outbreak response to Level 1, its most severe designation, signaling heightened public health risk.